(HPK) Highpeak Energy Acquisition - Ratings and Ratios
Crude Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.41% |
| Yield on Cost 5y | 1.05% |
| Yield CAGR 5y | 8.58% |
| Payout Consistency | 94.2% |
| Payout Ratio | 25.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 71.1% |
| Value at Risk 5%th | 117% |
| Relative Tail Risk | -0.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.32 |
| Alpha | -89.73 |
| CAGR/Max DD | -0.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.455 |
| Beta | 1.577 |
| Beta Downside | 2.337 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.28% |
| Mean DD | 51.97% |
| Median DD | 51.76% |
Description: HPK Highpeak Energy Acquisition November 15, 2025
HighPeak Energy, Inc. (NASDAQ: HPK) is an independent upstream firm focused on the exploration, development, and production of crude oil, natural gas, and natural-gas liquids in the Permian Basin, which spans West Texas and Eastern New Mexico. Founded in 2019 and based in Fort Worth, Texas, the company operates a common-stock vehicle listed in the United States under the Oil & Gas Exploration & Production GICS sub-industry.
As of its latest disclosed quarter, HPK reported an average daily oil production of roughly 1,800 boe/d, with a cash-flow conversion rate near 70 % of net income-a metric that signals decent operational efficiency for a relatively young shale player. The Permian Basin continues to benefit from a low-cost drilling environment (average all-in-place cost ≈ $12/boe) and strong infrastructure capacity, both of which underpin HPK’s ability to scale output if oil prices stay above the $70-$80 per barrel range that historically drives capital spending in the region.
If you’re looking to deepen your analysis, ValueRay’s platform offers a granular view of HPK’s cost structure, debt profile, and peer-group benchmarks-making it a useful next step for a data-driven assessment.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (53.2m TTM) > 0 and > 6% of Revenue (6% = 52.9m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -2.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.19% (prev -0.96%; Δ 12.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 558.0m > Net Income 53.2m (YES >=105%, WARN >=100%) |
| Net Debt (-134.9m) to EBITDA (630.6m) ratio: -0.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.65 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (124.8m) change vs 12m ago -3.32% (target <= -2.0% for YES) |
| Gross Margin 31.48% (prev 36.20%; Δ -4.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 28.14% (prev 37.10%; Δ -8.96pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.44 (EBITDA TTM 630.6m / Interest Expense TTM 148.9m) >= 6 (WARN >= 3) |
Altman Z'' 1.44
| (A) 0.03 = (Total Current Assets 251.3m - Total Current Liabilities 152.7m) / Total Assets 3.20b |
| (B) 0.14 = Retained Earnings (Balance) 463.3m / Total Assets 3.20b |
| (C) 0.07 = EBIT TTM 213.8m / Avg Total Assets 3.13b |
| (D) 0.29 = Book Value of Equity 463.3m / Total Liabilities 1.58b |
| Total Rating: 1.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.90
| 1. Piotroski 5.0pt |
| 2. FCF Yield 9.75% |
| 3. FCF Margin 4.72% |
| 4. Debt/Equity 0.02 |
| 5. Debt/Ebitda -0.21 |
| 6. ROIC - WACC (= -4.43)% |
| 7. RoE 3.26% |
| 8. Rev. Trend 50.33% |
| 9. EPS Trend -33.13% |
What is the price of HPK shares?
Over the past week, the price has changed by +5.63%, over one month by -31.83%, over three months by -33.27% and over the past year by -67.73%.
Is HPK a buy, sell or hold?
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HPK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.3 | 97.2% |
| Analysts Target Price | 9.3 | 97.2% |
| ValueRay Target Price | 3.9 | -17.7% |
HPK Fundamental Data Overview December 26, 2025
P/E Trailing = 11.4103
P/E Forward = 10.6045
P/S = 0.6367
P/B = 0.3436
Beta = 1.068
Revenue TTM = 881.5m USD
EBIT TTM = 213.8m USD
EBITDA TTM = 630.6m USD
Long Term Debt = 1.16b USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 30.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -134.9m USD (from netDebt column, last quarter)
Enterprise Value = 426.4m USD (561.3m + Debt 30.0m - CCE 164.9m)
Interest Coverage Ratio = 1.44 (Ebit TTM 213.8m / Interest Expense TTM 148.9m)
FCF Yield = 9.75% (FCF TTM 41.6m / Enterprise Value 426.4m)
FCF Margin = 4.72% (FCF TTM 41.6m / Revenue TTM 881.5m)
Net Margin = 6.03% (Net Income TTM 53.2m / Revenue TTM 881.5m)
Gross Margin = 31.48% ((Revenue TTM 881.5m - Cost of Revenue TTM 604.0m) / Revenue TTM)
Gross Margin QoQ = 23.77% (prev 26.48%)
Tobins Q-Ratio = 0.13 (Enterprise Value 426.4m / Total Assets 3.20b)
Interest Expense / Debt = 120.1% (Interest Expense 36.0m / Debt 30.0m)
Taxrate = 16.29% (-3.57m / -21.9m)
NOPAT = 179.0m (EBIT 213.8m * (1 - 16.29%))
Current Ratio = 1.65 (Total Current Assets 251.3m / Total Current Liabilities 152.7m)
Debt / Equity = 0.02 (Debt 30.0m / totalStockholderEquity, last quarter 1.63b)
Debt / EBITDA = -0.21 (Net Debt -134.9m / EBITDA 630.6m)
Debt / FCF = -3.25 (Net Debt -134.9m / FCF TTM 41.6m)
Total Stockholder Equity = 1.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.66% (Net Income 53.2m / Total Assets 3.20b)
RoE = 3.26% (Net Income TTM 53.2m / Total Stockholder Equity 1.63b)
RoCE = 7.66% (EBIT 213.8m / Capital Employed (Equity 1.63b + L.T.Debt 1.16b))
RoIC = 6.79% (NOPAT 179.0m / Invested Capital 2.63b)
WACC = 11.23% (E(561.3m)/V(591.3m) * Re(11.83%) + (debt cost/tax rate unavailable))
Discount Rate = 11.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.24%
[DCF Debug] Terminal Value 55.51% ; FCFE base≈71.0m ; Y1≈46.6m ; Y5≈21.3m
Fair Price DCF = 2.04 (DCF Value 256.3m / Shares Outstanding 125.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -33.13 | EPS CAGR: -48.06% | SUE: -0.82 | # QB: 0
Revenue Correlation: 50.33 | Revenue CAGR: 18.90% | SUE: -0.93 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.03 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.12 | Chg30d=-0.915 | Revisions Net=+1 | Growth EPS=-66.2% | Growth Revenue=-8.1%
Additional Sources for HPK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle